Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Biotech/Pharma - Investor
ProSensa Holding N.V. (RNA) Announces Intent To Voluntarily Delist From NASDAQ 1/30/2015 7:37:05 AM
Vitae Pharmaceuticals, Inc. (VTAE) Announces Exercise Of Underwriters' Option To Purchase Additional Shares And Closing Of Follow-On Public Offering Of Common Stock 1/29/2015 7:45:42 AM
Oxford Immunotec Limited (OXFD) Announces Proposed Underwritten Offering Of Ordinary Shares 1/29/2015 7:46:44 AM
Omeros Corporation (OMER) Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants 1/29/2015 7:30:11 AM
Mirati Therapeutics  (MRTX) Announces Proposed Public Offering Of Common Stock 1/29/2015 7:33:19 AM
OXIS International, Inc. (OXIS) Announces Approval For Up-Listing To The OTCQB 1/29/2015 8:01:00 AM
Auspex Pharmaceuticals (ASPX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 1/29/2015 7:42:55 AM
Zafgen (ZFGN) Announces Closing Of Public Offering Of Common Stock And Full-Exercise Of Option To Purchase Additional Shares 1/29/2015 7:43:45 AM
Otonomy, Inc. (OTIC) Announces Closing Of Follow-On Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 1/29/2015 7:44:44 AM
InVivo Therapeutics Corporation (NVIV) Announces $12 Million Registered Direct Offering 1/29/2015 10:02:47 AM
XenoPort, Inc. (XNPT) Announces Pricing Of $100 Million 2.50% Convertible Senior Notes Due 2022 1/29/2015 10:11:02 AM
Mylan Inc. (MYL) Shareholders Overwhelmingly Approve Agreement Implementing Acquisition Of Abbott Laboratories (ABT)'s Non-U.S. Developed Markets Specialty And Branded Generics Business 1/29/2015 10:36:40 AM
Cleveland Biolabs Inc. (CBLI) Announces Results Of Special Meeting Of Stockholders And Reverse Stock Split 1/29/2015 10:55:43 AM
Future Of Healthcare Investor Forum Highlights Investment Opportunity In UK Life Sciences 1/29/2015 2:02:28 PM
Celgene (CELG), Merck & Co. (MRK) Prime Examples of Novel Science "Renaissance," Says VC 1/29/2015 2:14:22 PM
1234567
//-->